Therapeutic Asset Ratings
144 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
cc-5013
Chronic Lymphocytic Leukemia
Vitebsk Regional Clinical Cancer Centre
P3
B
(62)
DEXAMETHASONE
Chronic Lymphocytic Leukemia
City of Hope Medical Center
P3
B
(62)
Evomela
Chronic Lymphocytic Leukemia
Center for International Blood and Marrow Transplant Research
P2
B
(62)
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER
Chronic Lymphocytic Leukemia
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
P2
B
(62)
TACROLIMUS
Chronic Lymphocytic Leukemia
Center for International Blood and Marrow Transplant Research
P3
B
(61)
Anti-Thymoglobulin, Rabbit
Chronic Lymphocytic Leukemia
M.D. Anderson Cancer Center
P2
B
(61)
Bgb-16673
Chronic Lymphocytic Leukemia
M.D. Anderson Cancer Center
P3
B
(60)
Duvelisib
Chronic Lymphocytic Leukemia
Ruijin Hospital
P3
B
(60)
FILGRASTIM
Chronic Lymphocytic Leukemia
City of Hope Medical Center
P3
B
(60)
Nemtabrutinib
Chronic Lymphocytic Leukemia
Jennifer Woyach
P3
B
(60)
Epirubicin
Chronic Lymphocytic Leukemia
Roswell Park Cancer Institute
P2
B
(60)
Pembrolizumab
Chronic Lymphocytic Leukemia
Roswell Park Cancer Institute
P2
B
(60)
Idelalisib
Chronic Lymphocytic Leukemia
Eli Lilly and Company
P4
B
(59)
5-azacytidine
Chronic Lymphocytic Leukemia
City of Hope Medical Center
P2
B
(59)
Tafasitamab
Chronic Lymphocytic Leukemia
City of Hope Medical Center
P2
B
(59)
Valganciclovir
Chronic Lymphocytic Leukemia
City of Hope Medical Center
P4
B
(58)
BMS-986345
Chronic Lymphocytic Leukemia
Ruijin Hospital
P3
B
(58)
Rapamycin
Chronic Lymphocytic Leukemia
Umoja Biopharma
P3
B
(58)
CIS-DIAMMINEDICHLOROPLATINUM II
Chronic Lymphocytic Leukemia
Mayo Clinic
P2
B
(58)
Mesna
Chronic Lymphocytic Leukemia
Center for International Blood and Marrow Transplant Research
P2
B
(58)
Zilovertamab
Chronic Lymphocytic Leukemia
University of California, San Diego
P2
B
(58)
Ublituximab
Chronic Lymphocytic Leukemia
TG Therapeutics, Inc.
P3
B
(56)
Thalidomide
Chronic Lymphocytic Leukemia
Institute of Hematology & Blood Diseases Hospital, China
P2
B
(56)
aciclovir
Chronic Lymphocytic Leukemia
City of Hope Medical Center
P2
CCC
(55)
Letermovir
Chronic Lymphocytic Leukemia
City of Hope Medical Center
P2
CCC
(55)
Showing 26 to 50 of 144 assets
Previous
Page 2 of 6
Next
